Currently the price is 0,38$, In this post we are going to talk about the listed company Brainstorm Cell Therapeutics Inc, its leaders are Alla Patlis (Chief Financial Officer & Controller), Chaim Lebovits (Chief Executive Officer), David Setboun (Chief Operating Officer & Executive Vice President), Ralph Z. Kern (President & Chief Medical Officer), Revital Geffen-Aricha (Vice President-Research & Development), Uri Yablonka (Secretary, Director, Chief Business Officer & EVP), Yael Gothelf (Vice President-Scientific & Regulatory Affairs), they lead it to work in Biotechnology: Biological Products (No Diagnostic Substances) especially in the North America region.
Yesterday this stock ended the day with a value of desconocido$.
With an intraday difference of 0,40$ moving between 0,37$ and 0,43$, it is a notable difference that allows quick purchases and sales.
The company has an annual revenue of desconocido.
The last registered opening is of desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.
Buscar
